科研动态PubMed 摘要

乙型肝炎表面抗原阳性或病毒血症供肾移植:系统综述与荟萃分析。

PubMed 学科轮询 · 2026-01-01

完整摘要 · 中文译文

目的:本系统综述和荟萃分析探讨了将HBV阳性供肾用于非病毒血症肾移植受者(KTRs)的相关证据。 方法:我们检索了截至2025年11月的PubMed和Embase数据库,并确定了接受乙型肝炎表面抗原阳性(HBsAg+)或病毒血症供肾受者的研究。以接受HBV阴性供肾的KTRs为对照组、报告患者生存率和移植物存活率的研究被纳入荟萃分析。汇总患者生存率和移植物存活率的风险比(RR),以获得移植后1年、3年和5年的估计值及95%置信区间。同时还综述了病毒传播情况,包括HBsAg阳转、HBV病毒血症或肝炎的发生。 结果:11项研究被纳入系统综述,6项被纳入荟萃分析。这些研究共纳入638例接受HBV阳性供肾的KTRs和2800例接受HBsAg阴性非病毒血症供肾的受者。在1年、3年和5年时,两组间移植物存活率的RR无统计学差异,分别为1 [0.98-1.01]、1.01 [0.98-1.04]和1.00 [0.91-1.09]。同样,两组间患者生存率的RR相当。HBV传播率较低(4.94%),尤其是在使用预防措施以及受者在移植前已具有免疫力的情况下。 结论:来自HBV感染供者的肾脏与来自HBV阴性供者的肾脏在患者生存率和移植物存活率方面相当。鉴于这一安全性新证据(传播率极低),在免疫KTRs中并配合适当的预防措施,可使用此类供肾以扩大供者池。 报告的传播率。

完整摘要 · 英文原文

PURPOSE: This systematic review and meta-analysis examines the evidence related to the use of HBV positive kidneys into non-viremic kidney transplant recipients (KTRs). METHODS: We searched PubMed and Embase through November 2025 and identified studies of recipients of hepatitis B surface antigen positive (HBsAg+) or viremic kidneys. Studies with a comparison group of KTRs of HBV negative kidneys that reported on patient and allograft survivals were included in the meta-analysis. The risk ratios (RR) for patient and allograft survivals were pooled to obtain the estimate and 95% confidence interval, at 1-, 3-, and 5-years post-transplant. Viral transmission including HBsAg development, HBV viremia, or hepatitis was also reviewed. RESULTS: Eleven studies were included in the systematic review and 6 in the meta-analysis. They included 638 KTRs of HBV positive kidneys and 2800 recipients of HBsAg negative non viremic kidneys. At 1, 3, and 5 years, the RR of allograft survival was not statistically different between the 2 groups and was 1 [0.98-1.01], 1.01 [0.98-1.04], and 1.00 [0.91-1.09] respectively. Similarly, the RR of patient survival was comparable between the 2 groups. The rate of HBV transmission was low (4.94%), especially when prophylaxis was used and when recipients were immune pre transplant. CONCLUSION: Kidneys from HBV infected donors confer similar patient and allograft survival than those from HBV negative donors. They may be used to expand the donor pool, in immune KTRs and with appropriate prophylaxis, in light of this emerging evidence of safety with very low reported rates of transmission.

English
Transplantation of Hepatitis B Surface Antigen Positive or Viremic Kidneys: A Systematic Review and Meta-Analysis.
内容仅供参考,不构成诊疗建议,不能替代执业医师的诊断。

← 返回元界